<?xml version="1.0" encoding="UTF-8"?>
<ref id="B85-marinedrugs-16-00256" class="ref">
 <label class="label">85.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Fang</surname>
    <given-names class="given-names">Y.P.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Yang</surname>
    <given-names class="given-names">S.H.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Lee</surname>
    <given-names class="given-names">C.H.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Aljuffali</surname>
    <given-names class="given-names">I.A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kao</surname>
    <given-names class="given-names">H.C.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Fang</surname>
    <given-names class="given-names">J.Y.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">What is the discrepancy between drug permeation into/across intact and diseased skins? Atopic dermatitis as a model</article-title>
  <source class="source">Int. J. Pharm.</source>
  <year class="year">2016</year>
  <volume class="volume">497</volume>
  <fpage class="fpage">277</fpage>
  <lpage class="lpage">286</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.ijpharm.2015.12.006</pub-id>
  <?supplied-pmid 26657274?>
  <pub-id pub-id-type="pmid" class="pub-id">26657274</pub-id>
 </element-citation>
</ref>
